Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

18.470
+0.6003.36%
Volume:5.10M
Turnover:93.69M
Market Cap:48.91B
PE:12.44
High:18.610
Open:17.880
Low:17.640
Close:17.870
52wk High:26.110
52wk Low:14.505
Shares:2.65B
HK Float Shares:530.00M
Volume Ratio:2.72
T/O Rate:0.96%
Dividend:0.46
Dividend Rate:2.47%
EPS(LYR):1.485
ROE:6.95%
ROA:1.40%
PB:0.86
PE(LYR):12.44
PS:0.98

Loading ...

FOSUN PHARMA Announces Wenjie Zhang Resigns as Co-President

Stock News
·
Yesterday

FOSUN PHARMA: BlackRock, Inc. Acquires Shares, Long Position Rises to 6.06%

HK Disclosure
·
Yesterday

Fosun Pharma Spends HK$189.36 Million on September H-Share Buy-backs, Expands Treasury Stock to 22.33 Million Shares

Bulletin Express
·
Yesterday

Sisram Medical Proposes New Sublicensing, Promo Services Pacts with Fosun Pharma's Unit

MT Newswires Live
·
Sep 29

Fosun Pharma Spends HK$1.0805 Million to Repurchase 62,000 Shares on September 25

Deep News
·
Sep 28

FOSUN PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 5.78%

HK Disclosure
·
Sep 25

Fosun Pharma Buys Back 72,000 H-Shares for HKD 1.27 Million, Lifts Treasury Stock to 22.27 Million Shares

Bulletin Express
·
Sep 24

FOSUN PHARMA Spends HK$1.2695 Million to Buy Back 72,000 Shares on September 24

Stock News
·
Sep 24

Sinopharm Group Stock Sheds 1.0% in Hong Kong

Dow Jones
·
Sep 24

Shanghai Fosun Unit Gets Global License for Two TCE Cancer Products

MT Newswires Live
·
Sep 23

Fosun Pharma Unit Secures Exclusive Global License for T-MATE™ Platform

Stock News
·
Sep 23

AH Premium Statistics Report | September 23

Stock News
·
Sep 23

Fosun Pharma Repurchases 1.20 Million H Shares for HKD 21.79 Million, Trimming Outstanding Float by 0.23%

Bulletin Express
·
Sep 22

Fosun Pharma Executes HKD 22.77 Million H-Share Buyback, Trimming Free Float by 0.24%

Bulletin Express
·
Sep 18

AH Share Premium Overview: Market Data as of September 18

Stock News
·
Sep 18

AH Share Premium Ranking Update for September 17

Stock News
·
Sep 17

FOSUN PHARMA Delivers Steady H1 2026 Growth Driven by Innovative Drugs and Overseas Sales

Bulletin Express
·
Sep 17

Fosun Pharma Publishes 2026 Interim Report Online; Shareholders May Request Free Printed Copies

Bulletin Express
·
Sep 17

Fosun Pharma buys back 1.30 million H shares for HKD 22.24 million

Bulletin Express
·
Sep 16

Fosun Pharma Spends HK$22.24 Million to Buy Back 1.3 Million Shares

Stock News
·
Sep 16